Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cytarabine -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cytarabine -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; mannitol; water for injections; hydrochloric acid; sodium hydroxide - as prescribed by the doctor, cisplatin is used as palliative treatment either in association with other therapies or in combination with other forms of chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - cisplatin is indicated for the treatment of: metastatic non-seminomatous germ cell carcinoma advanced and refractory carcinoma of the ovary; advanced and refractory carcinoma of the bladder; squamous cell carcinoma of the head and the neck.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - cisplatin is used as palliative treatment either in association with other therapies or in combination with other forms of chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: mannitol; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - cisplatin is indicated in metastatic, non seminomatous germ cell carcinoma, advanced stage and refractory ovarian carcinoma, advanced stages of refractory bladder carcinoma, advanced stages of refractory bladder carcinoma and squamous cell carcinoma of the head and neck. cisplatin is indicated in combination with other antineoplastic agents for the treatment of metastatic testicular tumors.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - cisplatin is indicated for the treatment of: metastatic carcinoma of non-seminoma germinale cells, advanced and refractory carcinoma of the ovary, advanced and refractory carcinoma of the bladder, epidemiological carcinoma of the head and the neck.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections - carboplatin injection is indicated for the treatment of ovarian cancer of epithelial origin in first line therapy, and in second line therapy after other treatments have failed.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - cisplatin is used in the treatment of certain types of cancer, for example ovarian cancer, testicular cancer, bladder cancer and head and neck cancer. cisplatin may be used in combination with other anti-cancer medicines.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: mannitol; sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - cisplatin sterile concentrate is an anti-cancer medicine in the form of a concentrate for infusion. cisplatin is used in the treatment of certain types of cancer, for example ovarian cancer, testicular cancer, bladder cancer and head and neck cancer. cisplatin may be used in combination with other anti-cancer medicines.